Evaluation of pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profile of free juglone and its sterically stabilized liposomes

B. Kiran Aithal, M. R. Sunil Kumar, B. Nageshwar Rao, Raghavendra Upadhya, Vijendra Prabhu, Gopal Shavi, Karthik Arumugam, Shyama Prasad Sajankila, N. Udupa, K. Satyamoorthy, B. S. Satish Rao

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The present study was aimed to formulate and compare the pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profiles of free 5-hydroxy-1,4-naphthoquinone (juglone) with sterically stabilized liposomal form. The liposomes were optimized for size, zeta potential, entrapment efficiency (EE), and in vitro release properties. The optimized formulation had a mean size, zeta potential, and EE value of 137.1 nm, -43.1 mV, and 67.2%, respectively. In vitro release studies showed biphasic pattern with initial burst followed by sustained release over the study period, releasing about 61% after 24 h. In vitro cytotoxicity studies against melanoma cells indicated that liposomal juglone was more toxic than free juglone. Free juglone had short plasma half-life of about 2 h, whereas liposomal juglone exhibited significantly improved pharmacokinetics with a 12-fold increase in plasma half-life. Further, biodistribution studies indicated rapid renal elimination of free juglone, evidenced by its significant localization in kidneys. Conversely, the accumulation of liposomal juglone in kidneys reduced significantly with enhanced tumor localization, thereby resulting in enhanced antitumor activity. The histological studies revealed lower levels of nephrotoxicity for liposomal juglone compared with that of free juglone. To conclude, sterically stabilized liposomes could be a promising approach for the intravenous delivery of hydrophobic compounds such as juglone.

Original languageEnglish
Pages (from-to)3517-3528
Number of pages12
JournalJournal of Pharmaceutical Sciences
Volume100
Issue number8
DOIs
Publication statusPublished - 2011

Fingerprint

Liposomes
Pharmacokinetics
Half-Life
juglone
Kidney
Poisons
Melanoma

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Aithal, B. Kiran ; Sunil Kumar, M. R. ; Rao, B. Nageshwar ; Upadhya, Raghavendra ; Prabhu, Vijendra ; Shavi, Gopal ; Arumugam, Karthik ; Sajankila, Shyama Prasad ; Udupa, N. ; Satyamoorthy, K. ; Satish Rao, B. S. / Evaluation of pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profile of free juglone and its sterically stabilized liposomes. In: Journal of Pharmaceutical Sciences. 2011 ; Vol. 100, No. 8. pp. 3517-3528.
@article{1fdc452e5de44c1ba6bb5756cd5cbbb2,
title = "Evaluation of pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profile of free juglone and its sterically stabilized liposomes",
abstract = "The present study was aimed to formulate and compare the pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profiles of free 5-hydroxy-1,4-naphthoquinone (juglone) with sterically stabilized liposomal form. The liposomes were optimized for size, zeta potential, entrapment efficiency (EE), and in vitro release properties. The optimized formulation had a mean size, zeta potential, and EE value of 137.1 nm, -43.1 mV, and 67.2{\%}, respectively. In vitro release studies showed biphasic pattern with initial burst followed by sustained release over the study period, releasing about 61{\%} after 24 h. In vitro cytotoxicity studies against melanoma cells indicated that liposomal juglone was more toxic than free juglone. Free juglone had short plasma half-life of about 2 h, whereas liposomal juglone exhibited significantly improved pharmacokinetics with a 12-fold increase in plasma half-life. Further, biodistribution studies indicated rapid renal elimination of free juglone, evidenced by its significant localization in kidneys. Conversely, the accumulation of liposomal juglone in kidneys reduced significantly with enhanced tumor localization, thereby resulting in enhanced antitumor activity. The histological studies revealed lower levels of nephrotoxicity for liposomal juglone compared with that of free juglone. To conclude, sterically stabilized liposomes could be a promising approach for the intravenous delivery of hydrophobic compounds such as juglone.",
author = "Aithal, {B. Kiran} and {Sunil Kumar}, {M. R.} and Rao, {B. Nageshwar} and Raghavendra Upadhya and Vijendra Prabhu and Gopal Shavi and Karthik Arumugam and Sajankila, {Shyama Prasad} and N. Udupa and K. Satyamoorthy and {Satish Rao}, {B. S.}",
year = "2011",
doi = "10.1002/jps.22573",
language = "English",
volume = "100",
pages = "3517--3528",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

Evaluation of pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profile of free juglone and its sterically stabilized liposomes. / Aithal, B. Kiran; Sunil Kumar, M. R.; Rao, B. Nageshwar; Upadhya, Raghavendra; Prabhu, Vijendra; Shavi, Gopal; Arumugam, Karthik; Sajankila, Shyama Prasad; Udupa, N.; Satyamoorthy, K.; Satish Rao, B. S.

In: Journal of Pharmaceutical Sciences, Vol. 100, No. 8, 2011, p. 3517-3528.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profile of free juglone and its sterically stabilized liposomes

AU - Aithal, B. Kiran

AU - Sunil Kumar, M. R.

AU - Rao, B. Nageshwar

AU - Upadhya, Raghavendra

AU - Prabhu, Vijendra

AU - Shavi, Gopal

AU - Arumugam, Karthik

AU - Sajankila, Shyama Prasad

AU - Udupa, N.

AU - Satyamoorthy, K.

AU - Satish Rao, B. S.

PY - 2011

Y1 - 2011

N2 - The present study was aimed to formulate and compare the pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profiles of free 5-hydroxy-1,4-naphthoquinone (juglone) with sterically stabilized liposomal form. The liposomes were optimized for size, zeta potential, entrapment efficiency (EE), and in vitro release properties. The optimized formulation had a mean size, zeta potential, and EE value of 137.1 nm, -43.1 mV, and 67.2%, respectively. In vitro release studies showed biphasic pattern with initial burst followed by sustained release over the study period, releasing about 61% after 24 h. In vitro cytotoxicity studies against melanoma cells indicated that liposomal juglone was more toxic than free juglone. Free juglone had short plasma half-life of about 2 h, whereas liposomal juglone exhibited significantly improved pharmacokinetics with a 12-fold increase in plasma half-life. Further, biodistribution studies indicated rapid renal elimination of free juglone, evidenced by its significant localization in kidneys. Conversely, the accumulation of liposomal juglone in kidneys reduced significantly with enhanced tumor localization, thereby resulting in enhanced antitumor activity. The histological studies revealed lower levels of nephrotoxicity for liposomal juglone compared with that of free juglone. To conclude, sterically stabilized liposomes could be a promising approach for the intravenous delivery of hydrophobic compounds such as juglone.

AB - The present study was aimed to formulate and compare the pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profiles of free 5-hydroxy-1,4-naphthoquinone (juglone) with sterically stabilized liposomal form. The liposomes were optimized for size, zeta potential, entrapment efficiency (EE), and in vitro release properties. The optimized formulation had a mean size, zeta potential, and EE value of 137.1 nm, -43.1 mV, and 67.2%, respectively. In vitro release studies showed biphasic pattern with initial burst followed by sustained release over the study period, releasing about 61% after 24 h. In vitro cytotoxicity studies against melanoma cells indicated that liposomal juglone was more toxic than free juglone. Free juglone had short plasma half-life of about 2 h, whereas liposomal juglone exhibited significantly improved pharmacokinetics with a 12-fold increase in plasma half-life. Further, biodistribution studies indicated rapid renal elimination of free juglone, evidenced by its significant localization in kidneys. Conversely, the accumulation of liposomal juglone in kidneys reduced significantly with enhanced tumor localization, thereby resulting in enhanced antitumor activity. The histological studies revealed lower levels of nephrotoxicity for liposomal juglone compared with that of free juglone. To conclude, sterically stabilized liposomes could be a promising approach for the intravenous delivery of hydrophobic compounds such as juglone.

UR - http://www.scopus.com/inward/record.url?scp=79958854094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958854094&partnerID=8YFLogxK

U2 - 10.1002/jps.22573

DO - 10.1002/jps.22573

M3 - Article

C2 - 21523783

AN - SCOPUS:79958854094

VL - 100

SP - 3517

EP - 3528

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 8

ER -